"10.1371_journal.pone.0085607","plos one","2014-01-21T00:00:00Z","Louise Balfour; Johanna N Spaans; Dean Fergusson; Harold Huff; Edward J Mills; Charles J la Porte; Sharon Walmsley; Neera Singhal; Ron Rosenes; Nancy Tremblay; M John Gill; Hugues Loemba; Brian Conway; Anita Rachlis; Edward Ralph; Mona Loutfy; Ranjeeta Mallick; Rika Moorhouse; D William Cameron","CIHR Canadian HIV Trials Network (CTN), Vancouver, British Columbia, Canada; Division of Infectious Diseases, Department of Medicine, University of Ottawa at the Ottawa Hospital, Ottawa, Ontario, Canada; Clinical Epidemiology Program, University of Ottawa at The Ottawa Hospital Research Institute (OHRI), Ottawa, Ontario, Canada; Canadian College of Naturopathic Medicine, Toronto, Ontario, Canada; Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada; Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada; Department of Medicine, The University of Ottawa, Ottawa, Ontario, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada; Division of Infectious Diseases, Department of Medicine, University of Western Ontario, London, Ontario, Canada; Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada","Â¶Membership of the MAINTAIN Study Group is provided in File S1.","The study medications and pharmaceutical stability reports on the formulation were supplied by K-PAX Inc. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. No proprietary interest or funding source has influence on the design, conduct or analysis of the trial.","2014","01","Louise Balfour","LB",19,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
